TAMs seems to have a role in treatment resistance, as macrophage inhibitors (e.g. colony stimulating factor 1 (CSF-1) inhibitor) prior to chemotherapy have been shown to enhance the response to treatment in mammary and cervical cancer (70, 71). Here, CSF1 is linked to cervical cancer.